HealthcareServices

Global Sexually Transmitted Infections (STIs) Market Report 2026–2030: Data-Driven Growth Insights

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the sexually transmitted infections (stis) market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Sexually Transmitted Infections (STIs) Market in 2030?

The market size for sexually transmitted infections (stis) has experienced rapid expansion in recent years. It is projected to grow from $71.28 billion in 2025 to $79.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.5%. The expansion observed historically can be attributed to a higher prevalence of STIs, constrained availability of early diagnostic instruments, increasing government campaigns for awareness, changes stemming from urbanization and lifestyle, and a rise in patient consultations at sexual health clinics.

The sexually transmitted infections (STIs) market is set to experience considerable growth in the coming years, with its value expected to reach $126.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.4%. This anticipated growth throughout the forecast period can be attributed to factors such as the increasing adoption of advanced molecular diagnostics, the expansion of at-home STI testing, greater integration with telemedicine platforms, enhanced funding for STI prevention programs, and the rise of AI-assisted diagnostic tools. Key trends during this period include the development of rapid point-of-care STI testing, a growing reliance on home-based STI test kits, an increase in vaccine development for STIs, the expanding adoption of combination diagnostic platforms, and escalating public awareness campaigns for STI prevention.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp

What Drivers Are Influencing Production Trends In The Sexually Transmitted Infections (STIs) Market?

Increased government efforts to raise awareness about sexually transmitted infections are projected to boost the sexually transmitted infections (STIs) market’s expansion. A government initiative is a policy or program put in place to achieve a particular objective and resolve specific issues. Governments provide various programs aimed at preventing, controlling, and treating STIs. These include funding public awareness campaigns, offering vaccines for specific STIs, and providing affordable or free screening and testing services. For instance, in April 2023, Springfield-Greene County Health, a public health department in the US, unveiled its Disease Intervention Specialist (DIS) program. This new initiative, a collaboration with the Missouri Department of Health and Senior Services (Missouri DHSS), aims to address the growing prevalence of sexually transmitted infections (STIs) within Greene County. The DIS program employs two specialists, primarily focusing on syphilis and HIV. Their role involves reaching out to individuals who test positive for these conditions, linking them to appropriate treatment options, and assisting in identifying and informing others who might be affected. Consequently, the rise in governmental initiatives is expected to propel the sexually transmitted infections (STIs) market.

Which Segments Are Gaining Traction In The Sexually Transmitted Infections (STIs) Market?

The sexually transmitted infections (stis) market covered in this report is segmented –

1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types

2) By Treatment: Antibiotics, Antiviral

3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing

4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2

2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV

3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea

4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis

5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis

Which Competitive Trends Are Impacting The Structure Of The Sexually Transmitted Infections (STIs) Market?

Leading firms within the sexually transmitted infections (STIs) market are creating advanced products utilizing fluorescent PCR technology, aiming for a competitive edge. Fluorescent PCR (Polymerase Chain Reaction) technology, a molecular biology method, enables the identification and measurement of particular DNA sequences found in biological samples. An example of this is when, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based company specializing in molecular diagnostic solutions, launched two novel polymer chain reaction (PCR) kits: the Mycoplasma Hominis Real-Time PCR Kit and the Treponema Pallidum Real-Time PCR Kit. These Kits offer a comprehensive PCR solution designed for the early detection of sexually transmitted illnesses, which affect a significant number of people. Specifically, the BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent employing fluorescent PCR technology for the detection of Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs, and urine samples. Meanwhile, the BioPerfectus Treponema Pallidum Real-Time PCR Kit is formulated to identify treponema pallidum nucleic acid in human serum and plasma.

Who Are The Primary Competitors In The Global Sexually Transmitted Infections (STIs) Market?

Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Sexually Transmitted Infections (STIs) Market?

North America was the largest region in the sexually transmitted infection (STIs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted infections (stis) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sexually Transmitted Infections (STIs) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13047&type=smp

Browse Through More Reports Similar to the Global Sexually Transmitted Infections (STIs) Market 2026, By The Business Research Company

Genital Herpes Market Report 2026

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Std Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Chlamydia Infection Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/chlamydia-infection-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795